MedPath

Effect of Amra-Lajadi Avleh in vomiting in pregnancy

Phase 3
Conditions
Health Condition 1: O210- Mild hyperemesis gravidarum
Registration Number
CTRI/2023/06/054095
Lead Sponsor
Department of prasuti evam stri roga College of ayurved and hospitalBharati Vidyapeeth
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a)Antenatal patients complaining of Nausea, vomiting.

(b)Age group 18-35 years.

(c)Both primi and multigravida patients.

(d) Patient willing to sign the informed consent form.

3

Exclusion Criteria

(a)Patients with hyperemesis gravidarum.

(b)Immuno-compromised patients.

(c)Patients taking medicines for any other systemic illness. (d)Known case of HTN, GDM.

(e)Vomiting due to other medical and surgical illnesses

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs & symptoms of Garbhini Chardi- Nausea,Number of episodes of vomiting,headache,weaknessTimepoint: 7 days
Secondary Outcome Measures
NameTimeMethod
Improvement in appetite and amount of intake.Timepoint: 7 days
© Copyright 2025. All Rights Reserved by MedPath